Compounds in development act on targets like fatty acid synthase and carnitine palmitoyl transferase FASgen is studying the effects of inhibition of the fatty acid biosynthesis pathway on the regulation of appetite and weight loss. The firm has developed various families of compounds that act on well-identified targets in the pathway, including fatty acid synthase FAS , carnitine palmitoyl transferase-1 CPT-1 , and mitochondrial glyceraol-3aclytransferase GPAT. The research is partly conducted in cooperation with labs at Johns Hopkins University. FASgen was founded in by four researchers from Johns Hopkins to create therapeutics based on the selective inhibition of fatty acid biosynthesis. The company has an exclusive license from Johns Hopkins to more than 15 years of research in the field. An additional group of compounds have shown potential in the treatment of tuberculosis TB including multiple drug-resistant TB and latent TB infections.
Main navigation - Mobile
Research & Development
Method of neuroprotection by pharmacological inhibition of AMP-activated protein kinase. Patent number: Abstract: A method of neuroprotection which comprises administration of an AMPK inhibitor to a patient who is experiencing or has experienced a stroke, the compound being an AMPK inhibitor.
I volunteer every week, I put others before myself, etc. Wow i am in the exact same position. Once she realizes you won't join and she can't get married in the temple, then I suspect everything will be over. For every lesson and sermon preached about loving everyone, there are one or two lessons on avoiding outsiders because they will destroy your eternity. You have been blessed with the equipment to make such decisions.